Related Experiment Video
Updated: Feb 22, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015
Abstract:
We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan during 2008-2015. The highest prevalence of macrolide-resistant M. pneumoniae was 81.6% in 2012, followed by 59.3% in 2014 and 43.6% in 2015. The prevalence of macrolide-resistant M. pneumoniae among children in Japan has decreased.
Insights
Macrolide-resistant Mycoplasma pneumoniae infections in Japanese children decreased significantly after 2012. This study tracked resistance trends from 2008-2015, showing a notable decline in resistant strains.
Area of Science:
- Pediatric infectious diseases
- Antimicrobial resistance surveillance
- Molecular epidemiology
Background:
- Mycoplasma pneumoniae is a common cause of respiratory infections in children.
- Macrolide antibiotics are a primary treatment for M. pneumoniae infections.
- Increasing macrolide resistance in M. pneumoniae poses a significant public health challenge.
Purpose of the Study:
- To analyze the prevalence and trends of macrolide-resistant Mycoplasma pneumoniae in children in Japan.
- To evaluate the temporal changes in macrolide resistance from 2008 to 2015.
Main Methods:
- Isolates from children with M. pneumoniae infection were collected across Japan between 2008 and 2015.
- Macrolide resistance patterns were determined for the collected isolates.
- Prevalence data were analyzed to identify trends over the study period.
Main Results:
- The prevalence of macrolide-resistant M. pneumoniae peaked in 2012 at 81.6%.
- Following the peak, resistance prevalence decreased to 59.3% in 2014 and 43.6% in 2015.
- A significant downward trend in macrolide resistance was observed in the later years of the study.
Conclusions:
- The prevalence of macrolide-resistant Mycoplasma pneumoniae in Japanese children has shown a decreasing trend since 2012.
- Continued surveillance is crucial to monitor antimicrobial resistance patterns in M. pneumoniae.
- Understanding these trends can inform treatment guidelines and public health strategies.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:

